Establishment Labs Holdings (ESTA) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

Establishment Labs Holdings (ESTA) overview

Establishment Labs Holdings (ESTA) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 211m and operating profit of USD -39.0m; the year-end share price was 72.88 USD and market capitalisation was USD 2,136m. Establishment Labs Holdings is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Establishment Labs Holdings's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 23.5mFY 2025
Share price72.88 USDFY 2025 year end
RevenueUSD 211mFY 2025
Operating profitUSD -39.0mFY 2025
Net earningsUSD -51.1mFY 2025
Market capitalisationUSD 2,136mFY 2025 year end

About Establishment Labs Holdings

Establishment Labs is a medical technology company focused on breast aesthetics and reconstruction. Its product portfolio centers on Motiva silicone gel-filled breast implants, including Round, Ergonomix, Anatomical and Ergonomix2 families, as well as the Flora Tissue Expander. Products are sold through exclusive distributors or the company’s direct sales force, serving the breast augmentation and reconstruction market.

Generate the Establishment Labs Holdings report

Establishment Labs Holdings is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Establishment Labs Holdings and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Establishment Labs Holdings

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.